ConductScience.org, home

Paper41299728

Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer's disease pathogenesis: implications for precision therapeutics.

Vaziri Y and 3 others. Mol Brain, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer's disease pathogenesis: implications for precision therapeutics. Papers, record 41299728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41299728

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer's disease pathogenesis: implications for precision therapeutics.
PubMed
Journal
Mol Brain
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.52, provisional
iCite
Revised in PubMed
2026-09-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vaziri YYashar
2Olia JBHJaleh Bagheri Hamzyan
3Avci CBCigir Biray
4Nourazarian AAlireza

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Gastrointestinal MicrobiomeMajor topic
DysbiosisMajor topic
Precision MedicineMajor topic
Humans
Animals

References149

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138849944Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial.Alzheimers Res Ther2024https://conductscience.org/library/papers/38849944PubMed
238791415Gut-Brain Axis: Focus on Sex Differences in Neuroinflammation.Int J Mol Sci2024https://conductscience.org/library/papers/38791415PubMed
332471946Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiome.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32471946PubMed
439195495Systematic Insights into the Relationship between the Microbiota-Gut-Brain Axis and Stroke with the Focus on Tryptophan Metabolism.Metabolites2024https://conductscience.org/library/papers/39195495PubMed
536831324Mechanisms of Blood-Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids.Cells2023https://conductscience.org/library/papers/36831324PubMed
640137277The Advancements of Marine Natural Products in the Treatment of Alzheimer's Disease: A Study Based on Cell and Animal Experiments.Mar Drugs2025https://conductscience.org/library/papers/40137277PubMed
738172602Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies.Exp Mol Med2024https://conductscience.org/library/papers/38172602PubMed
838916729Tryptophan Metabolism in Alzheimer's Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis.Aging Dis2024https://conductscience.org/library/papers/38916729PubMed
938137351Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut-Brain Axis.Biomedicines2023https://conductscience.org/library/papers/38137351PubMed
1039771027Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity.Nutrients2024https://conductscience.org/library/papers/39771027PubMed
1139780269Fecal microbiota transplantation attenuates Alzheimer's disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation.Behav Brain Funct2025https://conductscience.org/library/papers/39780269PubMed
1240791147Gut microbial metabolites and the brain-gut axis in Alzheimer's disease: A review.Biomol Biomed2025https://conductscience.org/library/papers/40791147PubMed
1339460538The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings.CNS Neurosci Ther2024https://conductscience.org/library/papers/39460538PubMed
1435855330Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease.Aging Dis2022https://conductscience.org/library/papers/35855330PubMed
1540243712Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools.Int J Mol Sci2025https://conductscience.org/library/papers/40243712PubMed
1640059063Linking Circadian Rhythms to Gut-Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease.CNS Neurosci Ther2025https://conductscience.org/library/papers/40059063PubMed
1736797287Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids.Sci Rep2023https://conductscience.org/library/papers/36797287PubMed
1839662839The complex relationship between gut microbiota and Alzheimer's disease: A systematic review.Ageing Res Rev2025https://conductscience.org/library/papers/39662839PubMed
1939608999
Monitoring drug Efficacy through Multi-Omics Research initiative in Alzheimer's Disease (MEMORI-AD): A protocol for a multisite exploratory prospective cohort study on the drug response-related clinical, genetic, microbial and metabolomic signatures in Filipino patients with Alzheimer's disease.
BMJ Open2024https://conductscience.org/library/papers/39608999PubMed
2038717124Fecal microbiota transplantation: current challenges and future landscapes.Clin Microbiol Rev2024https://conductscience.org/library/papers/38717124PubMed

See all 149 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42974103The Gut-Brain Homeostatic Continuum in Alzheimer's disease: a systems framework for physiological resilience and disease progression.Front Neurosci2026https://conductscience.org/library/papers/42974103PubMed
42877500The gut-brain axis in Alzheimer's and Parkinson's diseases: a comparative perspective.Front Microbiomes2026https://conductscience.org/library/papers/42877500PubMed
42794551The Tryptophan-Kynurenine Pathway as a Key Mediator of the Gut-Brain Axis in Depression and Alzheimer's Disease.Int J Mol Sci2026https://conductscience.org/library/papers/42794551PubMed
42630799The potential connection between inflammatory bowel disease and Alzheimer's disease: mechanistic insights and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42630799PubMed
42321809Bacteria-derived glutarate mitigates Alzheimer's disease model pathology through autophagy-lysosomal pathway.Cell Commun Signal2026https://conductscience.org/library/papers/42321809PubMed
42319691A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer's Disease Axis.Mol Neurobiol2026https://conductscience.org/library/papers/42319691PubMed
42223629The complex of gut microbial metabolites and sex hormones in Alzheimer's disease.Semin Immunopathol2026https://conductscience.org/library/papers/42223629PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41299728

GET https://conductscience.org/api/papers/v1/41299728/references?page=2